Beena Thannickal
| This email address is being protected from spambots. You need JavaScript enabled to view it.Media Specialist, UAB News
(205) 975-3967
beenat@uab.edu
Thannickal recently moved to Birmingham from Ann Arbor, Mich., where she was the senior PR specialist at the Institute for Research on Women and Gender at the University of Michigan. She previously worked at Boston University, specializing in research and science news, and she worked at PR firms in New York and Boston. While raising her three children she was a freelance writer for a women’s health magazine and a PR consultant for national clients. Beena’s professional roots started in Connecticut where she worked as a reporter at news organizations throughout the state. She has a bachelor's degree in journalism from the University of Connecticut. In her very little spare time, she likes to run and travel.
Beats: The UAB Comprehensive Cancer Center, cancer patient stories, cancer-related research
(205) 975-3967
beenat@uab.edu
Thannickal recently moved to Birmingham from Ann Arbor, Mich., where she was the senior PR specialist at the Institute for Research on Women and Gender at the University of Michigan. She previously worked at Boston University, specializing in research and science news, and she worked at PR firms in New York and Boston. While raising her three children she was a freelance writer for a women’s health magazine and a PR consultant for national clients. Beena’s professional roots started in Connecticut where she worked as a reporter at news organizations throughout the state. She has a bachelor's degree in journalism from the University of Connecticut. In her very little spare time, she likes to run and travel.
Beats: The UAB Comprehensive Cancer Center, cancer patient stories, cancer-related research
Yang’s research focuses on a new class of drug – PARP inhibitors – that interfere with a cancer cell’s ability to repair DNA damage, hastening cell death.
In honor of Breast Cancer Awareness Month in October, the BCRFA and other organizations are hosting several local events.
Clinicians will collaborate with local physicians, offering patients updated treatment recommendations and access to cutting-edge research.
Originally built in 1975, the Wallace Tumor Institute is the hub of the Comprehensive Cancer Center’s research and administrative enterprise.
On Friday, August 23, 2013, the Comprehensive Cancer Center will officially celebrate the grand opening of the recently renovated Wallace Tumor Institute.
The American Cancer Society is conducting the Cancer Prevention Study-3; enrollment is coming to UAB this fall.
Louise Chow, Ph.D., professor in the Department of Biochemistry and Molecular Genetics and senior scientist at the UAB Comprehensive Cancer Center, was elected a foreign associate of the National Academy of Sciences for excellence in original scientific research.
Biomarkers could tailor preventative or therapeutic aspirin regimens by predicting patients’ response.
Partridge, director of the UAB Comprehensive Cancer Center, was honored by the American Cancer Society for his exceptional talents and his commitment to make progress towards finishing the fight against cancer.
Proceeds from the Fiesta Ball are used to fund a competitive grant award for a young cancer researcher at UAB to jumpstart his or her research.